Form 8-K - Current report:
SEC Accession No. 0001517022-25-000004
Filing Date
2025-01-13
Accepted
2025-01-13 08:05:44
Documents
43
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akba-20250113.htm   iXBRL 8-K 34565
2 EX-99.1 akba_jpmpresox1122025xfi.htm EX-99.1 33537
7 akba_jpmpresox1122025xfi001.jpg GRAPHIC 42389
8 akba_jpmpresox1122025xfi002.jpg GRAPHIC 196594
9 akba_jpmpresox1122025xfi003.jpg GRAPHIC 47927
10 akba_jpmpresox1122025xfi004.jpg GRAPHIC 107511
11 akba_jpmpresox1122025xfi005.jpg GRAPHIC 103920
12 akba_jpmpresox1122025xfi006.jpg GRAPHIC 122254
13 akba_jpmpresox1122025xfi007.jpg GRAPHIC 93432
14 akba_jpmpresox1122025xfi008.jpg GRAPHIC 87935
15 akba_jpmpresox1122025xfi009.jpg GRAPHIC 117509
16 akba_jpmpresox1122025xfi010.jpg GRAPHIC 65282
17 akba_jpmpresox1122025xfi011.jpg GRAPHIC 98963
18 akba_jpmpresox1122025xfi012.jpg GRAPHIC 62986
19 akba_jpmpresox1122025xfi013.jpg GRAPHIC 100413
20 akba_jpmpresox1122025xfi014.jpg GRAPHIC 66265
21 akba_jpmpresox1122025xfi015.jpg GRAPHIC 93990
22 akba_jpmpresox1122025xfi016.jpg GRAPHIC 86353
23 akba_jpmpresox1122025xfi017.jpg GRAPHIC 117180
24 akba_jpmpresox1122025xfi018.jpg GRAPHIC 107068
25 akba_jpmpresox1122025xfi019.jpg GRAPHIC 31936
26 akba_jpmpresox1122025xfi020.jpg GRAPHIC 82625
27 akba_jpmpresox1122025xfi021.jpg GRAPHIC 36366
28 akba_jpmpresox1122025xfi022.jpg GRAPHIC 69075
29 akba_jpmpresox1122025xfi023.jpg GRAPHIC 96814
30 akba_jpmpresox1122025xfi024.jpg GRAPHIC 99199
31 akba_jpmpresox1122025xfi025.jpg GRAPHIC 165438
32 akba_jpmpresox1122025xfi026.jpg GRAPHIC 162450
33 akba_jpmpresox1122025xfi027.jpg GRAPHIC 201181
34 akba_jpmpresox1122025xfi028.jpg GRAPHIC 62555
  Complete submission text file 0001517022-25-000004.txt   3978505

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20250113.xsd EX-101.SCH 2139
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20250113_def.xml EX-101.DEF 3738
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20250113_lab.xml EX-101.LAB 25083
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20250113_pre.xml EX-101.PRE 14595
45 EXTRACTED XBRL INSTANCE DOCUMENT akba-20250113_htm.xml XML 2718
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 25524907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)